Abstract
It is currently impossible to non-invasively assess cerebellar cell structure during early development. Here we propose a novel approach to non-invasively and longitudinally track cell-specific development using diffusion-weighted magnetic resonance spectroscopy in combination with microstructural modelling. Tracking metabolite diffusion allows us to probe cell-specific developmental trajectories in the cerebellum and thalamus of healthy rat neonates from post-natal day (P) 5 to P30. Additionally, by comparing different analytical and biophysical microstructural models we can follow the differential contribution of cell bodies and neurites during development. The thalamus serves as a control region to assess the sensitivity of our method to microstructural differences between the regions. We found significant differences between cerebellar and thalamic metabolites diffusion properties. For most metabolites, the signal attenuation is stronger in the thalamus, suggesting less restricted diffusion compared to the cerebellum. There is also a trend for lower signal attenuation and lower ADCs with increasing age, suggesting increasing restriction of metabolite diffusion. This is particularly striking for taurine in the thalamus. We use biophysical modelling to interpret these differences. We report a decreased sphere fraction (or an increased neurite fraction) with age for taurine and total creatine in the cerebellum, marking dendritic growth. Surprisingly, we also report a U-shape trend for segment length (the distance between two embranchments in a dendritic tree) in the cerebellum agreeing with age-matching morphometry of openly available 3D-Purkinje reconstructions. Results demonstrate that diffusion-weighted MRS probes early cerebellar neuronal development non-invasively.
Introduction
The cerebellum is a well-conserved structure across species and particularly across mammals. The cerebellar cortex is a highly folded structure organized in three layers: the molecular layer (containing the notable Purkinje cell dendritic trees), the Purkinje layer (containing the somas of Purkinje cells), and the granular layer (containing the granule cells). Projections to the deep cerebellar nuclei form the cerebellar white matter. Despite its small size (compared to the cerebrum), it contains more than half of the total brain neurons: this is mainly due to the granule cells, very small and densely packed cells, some of the smallest of the brain, presenting a very simple morphology1. On the other hand, the Purkinje cells are one of the largest types of neurons, and most complex cells in the brain. Cerebellar development is protracted2, starting from birth (or the last trimester of pregnancy) to a few weeks old in rodents (or 2 y.o. in humans)3. The cerebellum is involved in many basic and high-level functions, from motor control to social skills, and it is known to be affected in a number of neurodevelopmental disorders4.
During early development, neurons arborise. Their morphology becomes more complex and exhibits denser branching. In rodents, Purkinje cells’ dendritic trees start growing at birth. In 30 days, they evolve from a simple soma (∼10 µm diameter) to a large cell with a highly branched and planar dendritic tree (soma diameter ∼20 µm, area ∼10,000 µm2 in the mouse5). Purkinje cell morphology can be altered in autism spectrum disorders (ASD), as shown, post-mortem, in humans6, and in multiple mouse models of ASD. Specifically, they show an increased spine density in Tsc1 mutant mice7, an overgrowth of the dendritic tree and abnormal branching in PTEN KO mice8, a reduction of the dendritic tree in AUTS2 mice9; and general alterations in developmental disorders10–13. While cerebellar cell morphology is informative about brain development, there are very few translational techniques that allow for a non-invasive measure of their morphology.
All cerebellar outputs transit via the deep cerebellar nuclei (DCN), and a couple of them project to the thalamus before spreading to the cortex. The thalamus is considered as a relay station in the brain and contains about 60 nuclei on unique pathways. Some thalamic nuclei are involved in psychiatric disorders, and more specifically, the microstructure of the mediodorsal nucleus and the pulvinar nucleus are altered in schizophrenia and psychosis14. Some other nuclei are involved in neurodevelopmental disorders (e.g., the lateral reticular nuclei in ASD15). Generally, these disorders are associated with an altered thalamic connectivity14. Thalamocortical projections are crucial for the cytoarchitectural development of the cortex16,17.
Rodents reach adulthood after a couple of months and are an ideal model to study mammal brain development. Manganese-enhanced MRI (MEMRI) is particularly suited to study whole-brain early development in rodents, providing high structural contrast and speed of acquisition in neonates2,18, but the method is blind to the nature of the microstructural changes leading to the volumetric changes reported.
Magnetic resonance imaging (MRI) is the gold standard tool to access the properties of soft tissues in the body in a safe and non-invasive manner. Diffusion-weighted MRI (dMRI) measures the diffusion properties of water in the brain: constrained and hindered by cell membranes, water diffusion provides an indirect measure of the tissue microstructure19. However, water is ubiquitous, and can only partially disentangle the contribution from different tissue compartments (e.g. intra and extracellular space). Diffusion-weighted magnetic resonance spectroscopy (dMRS) measures the diffusion properties of metabolites in a large volume of interest. Brain metabolites are mostly intracellular, with some more specific to neurons (e.g., N-acetyl-aspartate, NAA, and glutamate, Glu) and others more specific to glial cells (e.g., choline compounds, tCho, and myo-inositol, Ins), therefore different cellular compartments can be resolved20. However, metabolites are 104-fold less concentrated than water, which necessitates large measurement volumes for dMRS (typically ∼8cm3 vs ∼8mm3 in dMRI in humans). Morphometric parameters can be extracted from dMRS experiments with multiple diffusion times and multiple diffusion-weightings, and they correlate with neuronal and glial morphologies extracted from histological measures in the healthy, adult mouse21,22. More specifically, it has been shown that myo-inositol diffusion properties reflect astrocytic morphology in an induced model of astrocytic hypertrophy23, and in a mouse model of demyelination where astrocytic activation was expected24. Choline compound’s diffusion properties were associated with microglial activation in human disease25, or in an LPS-induced brain inflammation model26. However, to the best of our knowledge, very few studies have used dMRS to probe changes in neuronal morphology, and none have attempted to probe neuronal development in early life.
Here, we propose a non-invasive method to monitor cellular brain development. Neurodevelopmental disorders, or even psychiatric disorders with a neurodevelopmental origin such as schizophrenia27, need better neurobiological characterisation during development28. We focus on two regions with different developmental timelines: the cerebellum and the thalamus. As described above, the cerebellum expands greatly after birth, when the Purkinje cells dendritic trees start growing. This slow maturation exposes the cerebellum longer to developmental insults. In contrast to the cerebellum, the thalamus develops relatively quickly, and its neurons expand and complexify more rapidly2,29 (Figure 1A).
By contrasting these two regions, we want to assess the sensitivity of the proposed method. We scanned developing rats from postnatal day five (P5) to P30. We first used MEMRI to confirm the protracted cerebellar development compared to the thalamus. We then acquired diffusion properties of metabolites to probe short- and long-range restriction (i.e., soma restriction and branching). To interpret our data, we applied two biophysical models (one analytical and one computational) to characterise the specific changes in microstructure. We expected monotonic changes in microstructural parameters in both regions, reflecting cell growth, with thalamic properties plateauing earlier than cerebellar properties. This is mostly what we report in our observations. However, we report a U-shape trend for the cerebellar segment length (Lsegment, the distance between two embranchments of a dendritic tree) that matches openly available 3D cell reconstructions. In contrast to common findings in the adult brain, we report that tNAA and Glu do not provide reliable morphological neuronal markers in neonates. We identify instead total creatine (tCr) and taurine (Tau) as more reliable markers for tracking early neuronal development. We believe that this is a promising method to track early neuronal development, particularly in the cerebellum, where microstructure changes drastically postnatally.
Results
Structural imaging confirms protracted cerebellar growth
Representative slices from intra-age non-linear registration are shown in Figure 2A, underlying the cerebellar unfolding. Both cerebellar and thalamic volumes are just below 50µl at P5 (Figure 2B). However, the segmentation at P5 is poor, as explained in Methods (Figure S1), hence data at this time point should be treated cautiously, although the cerebellum and the thalamus, which are medial line structures, are less affected by the atlas distortions.
The cerebellum triples in volume, between P5 and P30, reaching 90% of its P30 volume at P20, while the thalamus reaches 90% of the P30 volume at P15.
Metabolic profile changes with age
The metabolic profile changes noticeably between P5 and P30 as shown in Figure 3A. The absolute concentrations of metabolites, estimated by LCModel using the b0 averaged spectra, shown in Figure 3A, were normalised by the absolute concentration of macromolecules, MM (Figure 3B). Between P5 and P30, metabolite/MM ratios increase for tNAA, Glu, Gln and Ins, and decrease for Tau, Gly, PE and tCho. Note that the increase in tNAA signal with age is protracted in the cerebellum compared to thalamus and has not reached a plateau at P30. These results generally match the metabolic concentrations measured with gold-standard classical MRS in the striatum, cortex and hippocampus of developing rats reported in Reference 30. We observe that tCr/MM increases strongly in the cerebellum between P5 and P30 but appears stable in the thalamus, while Reference 30 reported a 30% increase between P7 and P28 in the 3 ROIs. However, they also reported a 30% increase of the macromolecular content during this developmental period, matching our tCr/MM observation in the thalamus.
Metabolite diffusion properties differ between regions and change with age
Thalamic (Figure 4A) and cerebellar (Figure 4B) signal attenuations up to b=30 ms/µm2 and ADCs at TM=100-1000 ms are shown for tNAA, Glu, tCr, Tau, tCho and Ins. These diffusion properties differ between both regions at each age (see Figure S2 for a region-to-region visual comparison). For most metabolites (except tCho), the signal attenuation is stronger in the thalamus, suggesting less restricted diffusion compared to the cerebellum. There is also a trend for lower signal attenuation and lower ADCs with increasing age, suggesting increasing restriction of metabolite diffusion. This is particularly striking for Tau in the thalamus. To give an estimation of the MRS fit performance, CRLBs are given for tNAA, Glu, tCr, Tau, tCho and Ins for the different diffusion conditions in Table S1.
Biophysical modelling underlines different developmental trajectories of cell microstructure between the cerebellum and the thalamus
Data were fitted with a spheres + “astrosticks” model and a morphometric model (more details in the Methods section). The spheres + “astrosticks” model captures diffusion within spheres (representing cell bodies) and randomly oriented sticks (representing cell processes/neurites): parameters extracted are sphere fraction, fsphere (or equivalently neurite fraction as 1-fsphere) and cell radius, R. The parameter space (sphere radius vs sphere fraction) is represented in the 3rd column of Figure 4A (cerebellum) and Figure 4B (thalamus) for tNAA, Glu, tCr, Tau, tCho and Ins at all ages (see Figure S3 for a region-to-region visual comparison).
Mean values and standard deviations are reported in Table 1, along with the results from the linear mixed effect model ∼ Age + Region + Age:Region + (1|PupID). The fits on averaged data, for binned spectra by age and region, are shown in Figure S4.
The morphometric model, only applied to averaged ADCs at long td, interprets diffusion in branched structures: the segment length, Lsegment is reported on the last column of Figure 4A/B (see Figure S5 for a region-to-region visual comparison and Figure S6 for all parameters estimated by the morphometric model: Dintra, NBranch, Lsegment).
Neuronal markers
tNAA and Glu are primarily concentrated in neurons in adulthood.
Thalamus: The sphere fraction and the radius estimated from tNAA and Glu diffusion properties do not change much with age. For both metabolites, fsphere is around 0.25 and R decreases to 5-6 µm. Lsegment is stable with age for tNAA, but shows a reduction at P15-P20 for Glu.
Cerebellum: The sphere fraction and the radius estimated from tNAA diffusion properties vary with age. fsphere nears 0.5 in the cerebellum and R decreases below 5 µm for tNAA and Glu. Lsegment decreases until P15 for both tNAA and Glu.
Between regions, sphere fraction differs significantly (Table 1).
Glial markers
tCho and Ins are primarily concentrated in glial cells in adulthood. The general trend is a high sphere fraction (∼0.7-0.9) for Ins and moderately high (∼0.5-0.6) for tCho. The radius estimated from tCho differs significantly between regions. Note the trend of decreasing sphere fraction in the cerebellum with age. Data at P15 for Ins in the thalamus were individually not reliable enough to apply the spheres + astrosticks model (c.f. Table S1 and the particularly higher CRLBs at P15 for Ins).
Non-specific markers
tCr and Tau are not known to be compartmentalised in a specific cell-type.
Thalamus: Parameter estimates for tCr diffusion properties do not change substantially with age (fsphere∼0.35, R∼6.5µm). Tau parameters estimation varies a lot with age: R shows a substantial decrease and fsphere increases.
Cerebellum: fsphere decreases from 0.63 (P10) to 0.41 (P30), but R is stable. Tau follows a similar pattern, although with an overall lower fsphere (0.43 at P10 to 0.29 at P30). Lsegment increases in the cerebellum from P10 for tCr and increases P15 for Tau.
Between regions, the sphere fraction differs significantly for both metabolites (Table 1), but only Tau exhibits a significant change with age, and this change is different between regions (significant interaction term). For Tau, the radius is significantly different between regions, changes significantly with age and this change is different between regions (significant interaction term).
Discussion
As in Reference 2 we used MEMRI to validate the protracted development of the cerebellum in rat neonates3, unfolding and tripling volume between P5 and P30. Cell-specific cerebellar and thalamic microstructural features during early development in rat neonates were assessed with dMRS. We specifically report diffusion properties for neuronal markers tNAA and Glu, glial markers tCho and Ins, and the non-specific markers tCr and Tau. Metabolites exhibit significantly different diffusion properties between regions, demonstrating the relevance of dMRS to probe early cell structure development. The sphere fraction is notably higher in the cerebellum for metabolites compartmentalised fully (tNAA, Glu) or partially (tCr, Tau) in neurons, suggesting the cell-body dense granular layer of the cerebellum. The sphere fraction possibly reflects the relative volume of sphere-like structure (e.g., cell bodies) compared to the relative volume of fibrous structures (e.g., cell processes), illustrated in Figure 5A.
While soma morphologic maturation mostly happens in the first week31, dendritic expansion is rapid before P15 but then continues to mature up to the end of the 4th week31,32. Remarkably, the sphere fraction extracted from tCr and Tau decreases with age in the cerebellum only, potentially underlining the drastic Purkinje cell growth between birth and adulthood. The diffusion properties of glial metabolites, Ins and tCho, also display a trend to sphere fraction decrease with age. This could be explained by another cerebellar peculiarity, Bergmann glia develop long processes along Purkinje cells and this specific growth could play a role in the sphere fraction decrease of Tau and tCr.
We confirm in this study the observation from Reference 30 that both tCr and Tau have high spectroscopic signals in neonates. They are the two metabolites most reliably quantified up to P15 in both regions (continuing for Tau in the cerebellum up to P30) and the estimates of their diffusion properties are the most confident. The notable decrease of Tau concentration in the thalamus, the extreme sphere radius decrease, and the sphere fraction increase with age extracted from Tau diffusion properties may indicate a change in Tau compartmentation with age in the thalamus. Note that Tau has a higher Dintra33 compared to the other metabolites, potentially affecting the parameter estimation given for Tau. As described in Methods, the fit for taurine was substantially improved for Dintra > 0.6 µm2/ms. The results for Dintra=0.7 µm2/ms are similar for all the other metabolites (Figure S7), but it brings Tau sphere radius estimation to plausible values. However, in all cases, the increase in sphere fraction with age remains: at P5, fsphere(Tau) nears fsphere(tNAA), while at P30 fsphere(Tau) nears fsphere(tCho). We can reasonably hypothesize that Tau is relatively more concentrated in neurons at birth and loses its neuronal compartmentalisation with neuronal maturation, ending up concentrated in glial cells. Moreover, the volume taken by glial cells in the brain is lower than the volume taken by neurons: the decrease in Tau signal matches this proposed switch. Tau is crucial in early development, and it has been shown in cats (who are unable to synthetise Tau, and instead must source it from their diet), that Tau dietary deficiency delays cortical and cerebellar maturation34. Older immunohistochemistry studies associated Tau with Purkinje cells specifically35,36 and Tau levels in the cerebellum are still high at P30, matching the protracted development of Purkinje cells and the cerebellum. Moreover, Tau’s decreasing sphere fraction indicates that it stays relatively highly concentrated in neurons until P30, following the neuronal cerebellar growth and complexification (Figure 5A&C). Given that the low tNAA and Glu signal up to P10 (inclusive), particularly in the cerebellum, prevents confident inference of their diffusion properties, we suggest Tau as a cerebellar marker of early neuronal development, and possibly more specifically to Purkinje cells. Total creatine stands as a good marker too. However, there is no indication of a preferential neuronal compartmentation for this metabolite during early development, hence it is less specific to neurons. This is confirmed by the higher fsphere(tCr) compared to fsphere(Tau) up to P15 in the cerebellum.
We also observed a protracted increase in tNAA signal in the cerebellum compared to the thalamus. tNAA is usually described as a neuronal osmolyte, meaning it could reflect neuronal growth and maturation and be a marker of neuronal development. However, at the voxel level, its signal also reflects the neuronal volumetric contribution, i.e. differences in neuronal densities might mask the effect of development. In contrast, we want to reiterate that dMRS is a normalised measure and dMRS outcomes are not affected by the neuronal density: they represent the average morphological properties of the cell types the metabolite belongs to.
We chose to interpret the dMRS data with two biophysical models: an analytical spheres & “astrosticks” model and a computational morphometric model. The analytical model was applied simultaneously to the signal attenuation at high b-values and the ADCs at long diffusion times, and on individual animals. In addition to the valuable biophysical biomarkers, it provides a good signal representation to evaluate the significance of the differences between diffusion properties of individual datasets. The experimental design was not suitable for a randomly oriented infinite cylinders (“astrocylinders”) model as in previous studies22,23. The mixing time used for the acquisition of signal decay at high b-values (TM=100 ms) is too long to enable sensitivity to fibre radius37, hence the choice of “astrosticks” model. The sphere compartment was added to account for the high sphere fraction in the cerebellum, and for the nature of the neonatal brain (under-developed neurons). The RMSEs from the different models tested (Figure S2) tend to be more similar at P30, suggesting that it is less important to add a sphere compartment for modelling metabolites diffusion in the adult brain.
The computational morphometric model was applied to attempt to extract cell extension-related parameters, but the study design and data quality are suboptimal, and we could only reliably extract Lsegment and Dintra (Figure S6). Dintra is mostly stable with age in both regions. However, it sometimes drops or peaks, likely affecting the other parameters’ estimations. The longest mixing time (TM=1000 ms) is short compared to previous studies using a similar modelling approach21,23, meaning that the diffusion path is shorter (i.e., about 30µm in this study compared to about 45µm in previous studies, assuming Dintra=0.5 µm2/ms). Note that the higher Dintra of Tau is therefore an asset for probing early neuronal cerebellar growth. In our study, the number of embranchments (Nbranch) was very poorly evaluated because of the high level of noise in the data. However, even with a better dataset quality and a more optimal study design, it is unlikely that the Nbranch estimation could reflect the Purkinje cell morphometry because of their size and complexity in adulthood.
Finally, we expected that Lsegment estimated from the morphometric model in the cerebellum would increase regularly with age, matching the dendritic tree development. For neuronal, or partly neuronal metabolites, we report an Lsegment decrease first. Except for tNAA, which consistently decreases in the cerebellum with age, Lsegment decreases until P15 for tCr, Tau and Glu and then increases, forming a U-shape curve. To better understand these results, we extracted the morphometries of developing Purkinje cells and developing thalamic interneurons (both in the mouse) from NeuroMorph.org. Interestingly, from these 3D reconstructed cells, we observe a decrease in Lsegment, 3D-recon up to P13 for Purkinje cells, whilst being quite stable in the thalamus (Figure 6), matching our non-invasive measurement trend. This could reflect the complexification of the dendritic tree following its expansion.
Conclusion
This study proposes diffusion-weighted MRS as a method to longitudinally and non-invasively measure cell-specific cerebellar and thalamic microstructural features during early development in rat neonates. We demonstrate the sensitivity of Taurine to early neuronal cerebellar development. This is a stepping-stone enabling further studies in pathological conditions.
Methods
Animals
Experiments were approved by the United Kingdom Home Office. 18 Sprague-Dawley rats (9 females) were scanned at P5, P10, P15, P20 and P30. Pups came from 3 litters (6 pups scanned per litter). Animals were induced with 4% isoflurane in oxygen and anaesthesia was maintained with 1-2% isoflurane in oxygen. Respiration was monitored with a breathing pillow. Temperature was monitored with a rectal probe, which was used as a cutaneous probe from P5 to P20 to avoid any risk of harm. Isoflurane level was adapted to keep the animals at 50-70 rpm and a warm water-circulation heating pad was used to keep the animals at 36-37°C during scanning. Pups were gently held with foam and protected tape to minimise motion, because the neonatal skull is not suitable for the use of ear bars.
For logistic reasons we could not acquire MEMRI for all litters. Animals from the second litter had manganese-enhanced anatomical scans. To this end, they were intraperitoneally injected with a 50 mg/kg solution of MnCl2 24 hours prior to the scan. Under the age of P10, the dam received the intraperitoneal injection, and the manganese was transferred to the neonates via the maternal milk2.
MRI acquisitions
Data were acquired on a 7T Biospec Bruker MRI scanner (Paravision 360.1, max gradient strength: 660 mT/m), equipped with a mouse quadrature cryoprobe, well-suited for rat neonates. An anatomical scan around the region of interest (thalamus or cerebellum) to place the voxel (T2-weighted, 2D RARE, R=8, 0.2 mm isotropic resolution, TE=33 ms, TR=3500 ms). For 6 animals, this scan was replaced by a whole brain manganese-enhanced anatomical scan (T1-weighted, 3D MGE, TE=2.4 s, TR=62 ms, 0.15 mm isotropic resolution).
dMRS acquisitions
A STELASER (Ligneul et al., MRM 2017) sequence (TE=34 ms, diffusion gradient duration, δ=5 ms) was used for dMRS acquisitions. The voxel was placed in the cerebellum for 9 pups, and in the thalamus for the other 9 pups. Voxel size was increased with age to follow brain growth. Diffusion-weighted spectra were acquired at 4 mixing times (TM) and 2 b-values (c.f. Table 2 for detailed parameters): a small “b0” used as a crusher for the stimulated echo, and b0+3 ms/µm2. Higher b-values were also acquired at the shortest diffusion time to probe restriction within cell bodies and enable inference of cell fraction and radius.
Processing
dMRS
Processing was achieved with a custom Matlab (The Mathworks) routine (https://github.com/clemoune/dmrs-neonates/tree/main/A_dMRS_processing):
Signals from different coils were combined, using the water signal at the lowest b-value and shortest diffusion time.
Outliers were identified and discarded, as described in42.
For each transient i, the mean absolute upfield signal (range 1.9-4.5 ppm), Mup(i) was computed.
Transients affected by motion are characterised by a clear drop of Mup(i). Transients falling below the median(Mup) - 3xMAD threshold were discarded.
Experiments at high b-values are more susceptible to changing gradient direction (particularly if the voxel contains white matter tracts). To predict its effect across b-values and overcome the small number of acquisitions per unique condition (i.e. a (b-value, direction) pair), a diffusion kurtosis tensor was computed based on Mup. The MAD calculated at b=0 was used as a “ground truth” MAD and was reported to higher b-values (per direction). High b-values acquisitions are more easily corrupted by motion and therefore present an artificially high MAD.
Individual transients were corrected for phase and frequency drifts and averaged across all diffusion directions (powder-averaged) via an arithmetic mean. In general, metabolites signal was visually detectable on single transients (with a line-broadening of 5 Hz), except at b=20,30 ms/µm2 at P5, rendering these acquisitions more susceptible to motion artefacts.
Any water residual was removed using a singular value decomposition method centred around the water region. If the baseline was heavily distorted despite this step due to very poor water suppression, the acquisition was discarded from the analysis.
Spectra were subsequently fitted with LCModel. The simulated basis set contained the following metabolites: Ace, Ala, Asp, Cr, GABA, Gln, Glu, Gly, GPC, GSH, Ins, sIns, Lac, NAA, NAAG, PCho, PCr, Tau, PE, and included a macromolecules (MM) baseline acquired experimentally (double-inversion recovery and b=10 ms/µm2).
Diffusion properties of NAA+NAAG (tNAA), Glu, Cr+PCr (tCr), Tau, GPC+PCho (tCho) and Ins are reported. In order to model both signal compartmentalisation and restricted diffusion by cell membranes, we investigated metabolites diffusion through two sets of measurements: i) the direction-averaged signal decay as a function of the diffusion weighting b, keeping the diffusion time constant at 104.25 ms (time between diffusion gradients Δ fixed at 105.91 ms and δ fixed at 5 ms) and varying the strength of the diffusion-sensitizing gradients; and ii) the apparent diffusion coefficient (ADC) as a function of increasing diffusion time (keeping δ fixed at 5 ms). For the measurements i), data are reported as the ratio S(b)/S(b=0). For the measurements ii), ADCs diffusion time dependencies are reported. ADCs are calculated following Negative ADCs were systematically removed as they point to a quantification error.
In the cerebellum, metabolites’ signal attenuation at P5 is always much stronger and quite far off the other time points. The macromolecules’ signal attenuation at high b-values is supposed to remain low43 and can be used as an internal probe for motion artefact33. However, the macromolecules’ signal attenuation is quite strong at P5 in the cerebellum (Figure S8), pointing out to a residual motion artefact despite careful processing. The spectroscopic signal in individual transients was too low at high b-values, notably in the cerebellum: it is possible that the spectral realignment failed.
MEMRI
The three first echoes of each MGE acquisition were averaged and denoised using the DenoiseImage function from the MINC toolbox, based on44. For each time point, an image with no obvious artefact and a good visual CNR was taken as the initial model and transformed into the Fischer atlas45 space. Images were then processed using registration_tamarack.py with the MAGeT segmentation in the available Pydpider pipelines46. Due to the large deformations between P30 and P5, the P30 timepoint could not be used as a reference. An adequate atlas from P15 was generated in a couple of iterations (using a P20 atlas as intermediary). It was then used as a reference atlas and reference timepoint for the pipeline. The olfactory bulb and the more frontal parts were poorly registered because the image often had an intensity drop there, but it did not affect the registration of caudal regions, such as the cerebellum and the thalamus. Image with strong intensity differences, or corrupted by motion were removed from the analysis. The registration did not work well at P5, even when attempting to use an atlas generated at P10 (that is already slightly distorted).
Analysis
Signal decays at high-b values (at TM=100 ms) and ADCs at varying diffusion times were fitted together with a spheres and “astrosticks” (corresponding to randomly oriented sticks) model using the functions implemented in DIVE (https://git.fmrib.ox.ac.uk/fsl/DIVE). We fitted the signal to:
Free parameters were R (sphere radius) and fsphere (sphere fraction). Dintra (i.e. the metabolite intracellular free diffusivity) was fixed for both compartments at 0.5 µm2/ms. Previous studies measuring brain metabolites diffusion properties at ultra-short diffusion-times33,47 estimated the intracellular free diffusivity at 0.5-0.6 µm2/ms for most metabolites (except Tau). However other studies using different (less direct) approaches reported lower Dintra21,22, hence we tested a range of reasonable Dintra. Dintra was fixed 0.3, 0.4, 0.5, 0.6, 0.7 and 0.8 µm2/ms. RMSEs between model fit and data were equivalent for all Dintra, except for Tau in the thalamus where increasing Dintra improved the fit, particularly until Dintra=0.5µm2/ms. Moreover, parameters estimation was unrealistic for low Dintra. Increasing Dintra between 0.5 µm2/ms and 0.7 µm2/ms did not change the trend of the results, except for Tau in the thalamus (see Figure S0 and Discussion). The fit was made robust to missing data (when excluded during processing).
To test for the model accounting best for our data, we tested different analytical models. RMSE between model fit and data were calculated for “astrosticks” only (1 free parameter, Dintra), “astrocylinders” (corresponding to randomly oriented infinite cylinders, 2 free parameters: Dintra and cylinder radius), spheres and astrosticks without constraint (3 free parameters) and spheres and astrosticks with Dintra fixed at 0.5 µm2/ms (Figure S0). RMSE were the lowest for spheres and astrosticks, and were very similar with and without the Dintra constraint. Hence the model with the least free parameters was chosen. Moreover, the results from the constrained spheres and astrosticks model were more stable and physically meaningful with the constraint on Dintra. The code used for the analysis can be found on: https://github.com/clemoune/dmrs-neonates/tree/main/B_Astrosticks_Spheres_model.
Long diffusion times
Average ADCs at varying diffusion times were fitted with the morphometric model introduced in21. Modeling was performed using the dictionary generated for23 with TM = 100, 750 ms predicted by interpolation, and a random forest regressor (‘treeBagger’ function in MatlabR2020b, with tree depth = 20; number of trees = 200 and other model hyper-parameters as per default) trained in a fully supervised fashion, using the ADCs time dependencies as input and the ground truth morphological parameters as targets; as loss function the mean squared error between predicted and ground truth parameters values was used. Parameters fitted were Dintra, Nbranch, Lsegment, SDNbranch and SDLsegment. Boundaries for fitting the model to data were respectively [0.1, 1], [2, 25], [5, 100], [2, 3] and [5, 10]. Given the data noise, only Lsegment and Dintra are estimated robustly. Fits for all parameters are shown in Supplementary Information.
Statistical analyses
Statistical analyses were run with R, using the “lmerTest48 package. To assess whether diffusion properties were significantly different in the 2 regions during development, we applied a linear mixed effect model to the parameters extracted from the spheres + “astrosticks” model (sphere fraction and sphere radius), using age and region as fixed effects, and a random intercept for pups ID. An analysis of variance enabled to identify whether the inclusion of an interaction term age*region was necessary or not. Results were corrected for multiple hypotheses testing with a Bonferroni correction (6 metabolites,2 parameters = 12 hypotheses). The threshold corrected p-value is 4.2e-3 for α=0.05 and 8.3e-4 for α=0.01.
Funding
This work was funded by Wellcome. The Wellcome Centre for Integrative Neuroimaging is supported by core funding from the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). For the purpose of Open Access, the corresponding author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. MP is supported by UKRI Future Leaders Fellowship (MR/T020296/2).
References
- 1.The Cerebellum – Structure and ConnectionsElsevier B.V. https://doi.org/10.1016/B978-0-444-51892-7.00001-2
- 2.4D MEMRI atlas of neonatal FVB/N mouse brain developmentNeuroimage 118:49–62https://doi.org/10.1016/j.neuroimage.2015.05.029
- 3.Emerging connections between cerebellar development, behaviour and complex brain disordersNat Rev Neurosci 20https://doi.org/10.1038/s41583-019-0152-2
- 4.The Cerebellum and Neurodevelopmental DisordersThe Cerebellum 15:34–37https://doi.org/10.1007/s12311-015-0715-3
- 5.Differential spatiotemporal development of Purkinje cell populations and cerebellum-dependent sensorimotor behaviorsElife :1–34
- 6.Purkinje Cell Size is Reduced in Cerebellum of Patients With AutismCell Mol Neurobiol 22:171–175
- 7.Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant miceNature 488:647–651https://doi.org/10.1038/nature11310
- 8.Autistic-Like Traits and Cerebellar Dysfunction in Purkinje Cell PTEN Knock-Out MiceNeuropsychopharmacology 41:1457–1466https://doi.org/10.1038/npp.2015.339
- 9.AUTS2 Governs Cerebellar Development, Purkinje Cell Maturation, Motor Function and Social CommunicationiScience 23https://doi.org/10.1016/j.isci.2020.101820
- 10.Altered branching patterns of Purkinje cells in mouse model for cortical development disorderSci Rep :1–7https://doi.org/10.1038/srep00122
- 11.Morphological and functional reversal of phenotypes in a mouse model of Rett syndromeBrain 135https://doi.org/10.1093/brain/aws096
- 12.Sumoylation of FOXP2 Regulates Motor Function and Vocal Communication Through Purkinje Cell DevelopmentBiol Psychiatry 81:220–230https://doi.org/10.1016/j.biopsych.2016.02.008
- 13.Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycinMol Psychiatry 23:2167–2183https://doi.org/10.1038/s41380-018-0018-4
- 14.Thalamic Connectivity System Across Psychiatric Disorders : Current Status and Clinical ImplicationsBiol Psychiatry Glob Open Sci 2:332–340https://doi.org/10.1016/j.bpsgos.2021.09.008
- 15.Thalamic Reticular Dysfunction as a Circuit Endophenotype in Neurodevelopmental DisordersNeuron 98:282–295https://doi.org/10.1016/j.neuron.2018.03.021
- 16.Developmental interactions between thalamus and cortex : a true love reciprocal storyCurr Opin Neurobiol 52:33–41https://doi.org/10.1016/j.conb.2018.04.018
- 17.Thalamocortical axons control the cytoarchitecture of neocortical layers by specific supply of VGFElife :1–23
- 18.Mouse MRI shows brain areas relatively larger in males emerge before those larger in femalesNat Commun 9https://doi.org/10.1038/s41467-018-04921-2
- 19.Imaging brain microstructure with diffusion MRI : practicality and applicationsNMR Biomed 32:1–26https://doi.org/10.1002/nbm.3841
- 20.Diffusion-Weighted Magnetic Resonance SpectroscopyeMagRes 4:733–750https://doi.org/10.1002/9780470034590.emrstm1471
- 21.New paradigm to assess brain cell morphology by diffusion-weighted MR spectroscopy in vivoProc Natl Acad Sci U S A 113:6671–6676https://doi.org/10.1073/pnas.1504327113
- 22.Modeling Diffusion of Intracellular Metabolites in the Mouse Brain up to Very High Diffusion-Weighting : Diffusion in Long Fibers (Almost) Accounts for Non-Monoexponential AttenuationMagn Reson Med 350:343–350https://doi.org/10.1002/mrm.26548
- 23.Diffusion-weighted magnetic resonance spectroscopy enables cell-specific monitoring of astrocyte reactivity in vivoNeuroimage 191:457–469https://doi.org/10.1016/j.neuroimage.2019.02.046
- 24.Inflammation-driven glial alterations in the cuprizone mouse model probed with diffusion-weighted magnetic resonance spectroscopy at 11 . 7 TNMR Biomed :1–13https://doi.org/10.1002/nbm.4480
- 25.Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolitesBrain 139:1447–1457https://doi.org/10.1093/brain/aww031
- 26.Diffusion-weighted MR spectroscopy (DW-MRS) is sensitive to LPS-induced changes in human glial morphometry : A preliminary studyBrain Behav Immun 99:256–265
- 27.The Neurodevelopmental Hypothesis of Schizophrenia, RevisitedSchizophr Bull 35:528–548https://doi.org/10.1093/schbul/sbn187
- 28.What are neurodevelopmental disorders ?Curr Opin Neurol :611–616https://doi.org/10.1097/WCO.0000000000000710
- 29.Large-Scale Somatotopic Refinement via Functional Synapse Elimination in the Sensory Thalamus of Developing MiceJ Neurosci 34:1258–1270https://doi.org/10.1523/JNEUROSCI.3865-13.2014
- 30.Developmental and Regional Changes in the Neurochemical Profile of the Rat Brain Determined by In Vivo 1 H NMR SpectroscopyMagn Reson Med 32:24–32https://doi.org/10.1002/mrm.10497
- 31.Physiological and morphological development of the rat cerebellar Purkinje cellJ Physiol 567:829–850https://doi.org/10.1113/jphysiol.2005.089383
- 32.Differential spatiotemporal development of Purkinje cell populations and cerebellum-dependent sensorimotor behaviorsElife
- 33.Probing metabolite diffusion at ultra-short time scales in the mouse brain using optimized oscillating gradients and “short”-echo-time diffusion-weighted MRSNMR Biomed 30:1–10https://doi.org/10.1002/nbm.3671
- 34.Taurine and taurine-deficiency in the perinatal periodJ Perinat Med 30:281–286
- 35.IMMUNOCYTOCHEMICAL VISUALIZATION OF TAURINE: NEURONAL LOCALIZATION IN THE RAT CEREBELLUMNeurosci Lett 60:255–260
- 36.Colocalization of Taurine-and Cysteine Sulfinic Acid Decarboxylase-like lmmunoreactivity in the Cerebellum of the Rat with Monoclonal Antibodies Against TaurineJ Neurosci 8
- 37.Diffusion-weighted MR spectroscopy : consensus, recommendations and resources from acquisition to modellingarXiv
- 38.Mitochondrial fission protein Drp1 regulates mitochondrial transport and dendritic arborization in cerebellar Purkinje cellsMol Cell Neurosci 71:56–65https://doi.org/10.1016/j.mcn.2015.12.006
- 39.Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6J Physiol 3:949–966https://doi.org/10.1113/JP273184
- 40.Mature Purkinje Cells Require the Retinoic Acid-Related Orphan Receptor-alpha-ROR alpha to Maintain Climbing Fiber Mono-Innervation and Other Adult CharacteristicsJ Neurosci 33:9546–9562https://doi.org/10.1523/JNEUROSCI.2977-12.2013
- 41.CKAMP44 controls synaptic function and strength of relay neurons during early development of the dorsal lateral geniculate nucleusJ Physiol 15:3549–3565https://doi.org/10.1113/JP283172
- 42.Rejecting or retaining motion corrupted transients in di ff usion-weighted MRS : high b-values and multiple directionsProc. Intl. Soc. Mag. Reson. Med. 31 (2023) 31
- 43.Metabolite diffusion up to very high b in the mouse brain in vivo: Revisiting the potential correlation between relaxation and diffusion propertiesMagn Reson Med 77:1390–1398https://doi.org/10.1002/mrm.26217
- 44.An Optimized Blockwise Nonlocal Means Denoising Filter for 3-D Magnetic Resonance ImagesIEEE Trans Med Imaging 27:425–441
- 45.An MRI-Derived Neuroanatomical Atlas of the Fischer 344 Rat BrainSci Rep 10:1–13https://doi.org/10.1038/s41598-020-63965-x
- 46.Pydpiper : a flexible toolkit for constructing novel registration pipelinesFront Neuroinform 8:1–21https://doi.org/10.3389/fninf.2014.00067
- 47.Anomalous diffusion of brain metabolites evidenced by diffusion-weighted magnetic resonance spectroscopy in vivoJ Cereb Blood Flow Metab 32https://doi.org/10.1038/jcbfm.2012.119
- 48.lmerTest Package : Tests in Linear Mixed Effects ModelsJ Statis 82https://doi.org/10.18637/jss.v082.i13
Article and author information
Author information
Version history
- Sent for peer review:
- Preprint posted:
- Reviewed Preprint version 1:
Copyright
© 2024, Ligneul et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.